Application 076130
- Type
- ANDA
- Sponsor
- DAVA PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | VOSPIRE ER | ALBUTEROL SULFATE | TABLET, EXTENDED RELEASE;ORAL | EQ 4MG BASE | No | No |
| 003 | VOSPIRE ER | ALBUTEROL SULFATE | TABLET, EXTENDED RELEASE;ORAL | EQ 8MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076130-002 | VOSPIRE ER | ALBUTEROL SULFATE | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | ||
| A076130-003 | VOSPIRE ER | ALBUTEROL SULFATE | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076130-002 | VOSPIRE ER | EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076130-003 | VOSPIRE ER | EQ 8MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2002-09-26 | 5d02ea3f76ae… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A076130-002 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076130-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A076130-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A076130-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A076130-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A076130-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A076130-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A076130-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate | ALBUTEROL SULFATE | Redpharm Drug | 5d62969b-2ad9-6cf0-e063-6394a90ac2f0 | 2026-10-09 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol sulfate | ALBUTEROL SULFATE | A-S Medication Solutions | 52e209ac-7156-4496-ba5a-42ee59d45deb | 2026-10-01 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | A-S Medication Solutions | a9188951-3711-412c-89c6-e8db784dcb65 | 2026-09-25 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| VENTOLIN HFA | ALBUTEROL SULFATE | REMEDYREPACK INC. | adb8d669-b91c-46f1-8a86-19f504840eff | 2026-09-24 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 1810ff8e-d505-bf9c-e063-6394a90a6540 | 2026-09-22 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Aurobindo Pharma Limited | eafa5b05-d692-48e7-a413-30f847547eb2 | 2026-09-22 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | REMEDYREPACK INC. | 54172384-9726-4a11-901e-3fb8f1baccae | 2026-09-15 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | REMEDYREPACK INC. | 32dbec5e-044a-40b6-9b88-e1396c4b4b6e | 2026-09-15 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | REMEDYREPACK INC. | b7c6ae06-b1a8-4bf1-934d-439572e19931 | 2026-09-14 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | Armstrong Pharmaceuticals, Inc. | 17858afa-dcdf-4612-b475-3b6baadfb639 | 2026-08-06 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals, Inc. | 583c6408-45cc-9121-e063-6294a90afcc4 | 2026-08-04 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3236f82c-14e9-dfd4-e063-6294a90ac43d | 2026-07-16 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 32377c09-da6d-331c-e063-6294a90a7a46 | 2026-07-16 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc | 32474c0e-af35-69d1-e063-6394a90a53c6 | 2026-07-16 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | HAWAII REPACK, INC. | b18fad6e-f117-4840-83b7-8c261c646af1 | 2026-07-03 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | 4aec7f59-b429-4b0e-a779-8df1dd8f80d7 | 2026-06-23 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | REMEDYREPACK INC. | 0f9bf2c8-55c0-4b4d-97de-d6c7220c3862 | 2026-06-17 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Cipla USA Inc. | c4d6d76a-14b8-411a-8019-e2c923c2c532 | 2026-05-20 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | b0a5da99-6553-4088-ae27-7fa194438340 | 2026-05-20 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
| Albuterol Sulfate | ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | 574824f3-51cc-4b94-9c10-e3204d8b19f8 | 2026-05-08 | Warnings, Adverse reactions | ALBUTEROL SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 43055 | ORIG | 2007-07-06 |